We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





LGC Clinical Diagnostics Presents Full Portfolio of Quality Measurement Tools

By LabMedica International staff writers
Posted on 25 Jul 2023
Print article
Image: LGC’s full portfolio of quality measurement tools is being displayed at AACC 2023 (Photo courtesy of LGC)
Image: LGC’s full portfolio of quality measurement tools is being displayed at AACC 2023 (Photo courtesy of LGC)

LGC Clinical Diagnostics (Middlesex, UK) is showcasing its full portfolio of quality measurement tools at AACC 2023 with complete access to its sub-brands including Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. LGC’s combined capabilities make it better positioned to support the needs of the clinical diagnostics industry, from early feasibility and research to commercial & laboratory development test (LDT) assay development, installation, validation, and ongoing performance monitoring support.

At AACC 2023, LGC is presenting VALIDATE linearity & calibration verification materials, ACCURUN reference materials & QC products, the Multichem range of independent quality controls, and the VirtuE range of antigens & antibodies. The VALIDATE ready-to-use kits from Maine Standards are designed to assist in the documentation of linearity, calibration verification, and verification of linear range required by many inspection agencies. VALIDATE also provides assistance when troubleshooting instrument systems, reagent problems, and calibration anomalies. LGC is also highlighting SeraCare’s ACCURUN controls and reference materials: which are designed to be weakly reactive to help monitor serology assays for additional confidence in laboratory test results. In addition, the Seraseq Next-generation sequencing (NGS) reference materials help scientists and clinicians build, validate, implement, and standardize better clinical genomics assays.

Visitors to the LGC booth at AACC 2023 can also learn more about the Multichem class-leading third-party test-consolidated QC product range from Technopath Clinical Diagnostics. The extensive list of analytes included in the Multichem product range guarantees quality, choice, and flexibility. Multichem ID controls can be used as part of the QConnect integrated and simplified QC solution. ​Also being highlighted by LGC at the show is the VirtuE range of antigens & antibodies from The Native Antigen Company that are produced using the company’s VirtuE mammalian expression system. These antigens are suitable for use in vaccine R&D, as components for serological-based diagnostic assays, and for fundamental research into infectious diseases.

Related Links:
LGC 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Francisella Tularensis Test
Francisella Tularensis Real Time PCR Kit
New
Gastrointestinal Infection Test
REALQUALITY ETEC/EIEC

Print article

Channels

Molecular Diagnostics

view channel
Image: Three newly identified protein biomarkers have the potential to improve diagnostic tools for colorectal cancer (Photo courtesy of Adobe Stock)

New Protein Biomarkers to Improve Diagnostic Tools for Colorectal Cancer

Colorectal cancer is a leading cause of cancer-related deaths globally, and its incidence is expected to rise in the coming decades. This cancer begins when abnormal cells grow uncontrollably in the large... Read more

Microbiology

view channel
Image: The CRISPR-TB Blood Test provides accurate, rapid, and cost-effective diagnosis (Photo courtesy of 123RF)

CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening

Tuberculosis (TB) continues to be a leading cause of global mortality, with 10.6 million new cases and 1.6 million deaths annually. Diagnosing TB remains difficult, with smear microscopy offering only... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.